OR52N1: A Potential Drug Target for Cancer and Neurological Diseases

OR52N1: A Potential Drug Target for Cancer and Neurological Diseases

OR52N1 (OR11-61) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the resource-sharing transfer RNA (SRTNA) family, which RNA is responsible for transporting genetic information within cells. The protein encoded by the OR52N1 gene is a ribosomal subunit, which is responsible for the synthesis of SRTNA protein in cells.

In recent years, researchers' studies of OR52N1 have shown that it may be a potential drug target (or biomarker). This is mainly because OR52N1 is expressed in a variety of cancers, including lung, breast, prostate and colon cancers. In addition, OR52N1 is also associated with a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, and depression.

In cancer research, OR52N1 is used as a target for therapeutic drugs. For example, researchers are exploring the use of OR52N1 inhibitors to treat lung cancer. In a clinical trial, researchers gave patients a drug called OR52N1 inhibitor orally and then measured the patients' survival and tumor size. The results show that OR52N1 inhibitor can significantly prolong the survival time of lung cancer patients and significantly reduce tumor size.

In addition to its use in cancer treatment, OR52N1 may also play a role in disease diagnosis and treatment. For example, some studies have shown that OR52N1 can serve as a potential therapeutic target for Alzheimer's disease. In this study, the researchers found that OR52N1 expression levels were positively correlated with the degree of cognitive decline in Alzheimer's disease patients. These findings provide a new idea for Alzheimer's disease treatment by reducing the concentration of OR52N1 to treat this disease.

In addition, OR52N1 is also associated with Parkinson's disease. In one study, researchers found that OR52N1 expression levels were higher in patients with Parkinson's disease than in healthy people. These findings provide a new target for Parkinson's disease treatment using drugs that reduce the expression levels of OR52N1 to treat this disease.

In addition to its use in cancer and neurological diseases, OR52N1 has been linked to mood disorders such as depression. In one study, researchers found that OR52N1 is associated with increased cortisol levels in people with mood disorders. These findings provide a new idea for the treatment of mood disorders, which is to use drugs that can reduce the expression level of OR52N1 to treat this disorder.

In conclusion, OR52N1 is a potential drug target (or biomarker) with important application value in the treatment of cancer and neurological diseases. Future studies will continue to explore the role of OR52N1 in the treatment of cancer and neurological diseases and provide new guidance for clinical practice.

Protein Name: Olfactory Receptor Family 52 Subfamily N Member 1

Functions: Odorant receptor

The "OR52N1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR52N1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4